Medpace Holdings revenue and financials
In the fiscal year ended December 2025, Medpace Holdings reported revenue of $2.53B (+19.97% year over year). Net income was $451.12M, a net margin of 17.8%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +19.97%
- 2025 vs 2024
- Net income growth
- +11.56%
- 2025 vs 2024
- Net margin
- 17.8%
- 2024: 19.2%
How Medpace Holdings is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 22.3% a year on average over the last 5 years
Compound annual growth rate: from $925.93M in 2020 to $2.53B in 2025.
Revenue has grown for 9 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin rose from 19.1% to 21.1%
Operating income over revenue, 2022 → 2025: 2.1 percentage points.
Profits turn into cash: free cash flow equal to 145% of net income
Totals for fiscal years 2023–2025: free cash flow $1.65B, net income $1.14B.
Shares outstanding down 21.7% in 5 years
Average diluted shares, 2020 → 2025: with fewer shares, each one represents a larger stake in the company.
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2,530 | 2,109 | 1,886 | 1,460 | 1,142 | 926 | 861 | 705 | 436 | 422 |
| Cost of revenue | 732 | 682 | 638 | 535 | 441 | 354 | 321 | 252 | 212 | 199 |
| Gross profit | 1,798 | 1,427 | 1,248 | 925 | 701 | 571 | 540 | 452 | 175 | 172 |
| Selling, general and administrative | 198 | 180 | 161 | 131 | 108 | 92.2 | 95.2 | 75.7 | 63.4 | 61.5 |
| Operating income | 535 | 447 | 337 | 279 | 199 | 167 | 127 | 101 | 64.9 | 52.5 |
| EBIT | 535 | 447 | 337 | 279 | 199 | 167 | 127 | 101 | 64.9 | 52.5 |
| EBITDA | 563 | 476 | 363 | 301 | 220 | 187 | 150 | 140 | 111 | 111 |
| Interest expense | — | — | 0.5 | 2.9 | 0.1 | — | 1.6 | 8.2 | 7.6 | 19.4 |
| Pre-tax income | 542 | 476 | 336 | 283 | 202 | 169 | 125 | 94.0 | 56.9 | 22.0 |
| Income tax | 91.3 | 71.5 | 52.9 | 37.5 | 20.0 | 23.1 | 24.4 | 20.8 | 17.8 | 8.5 |
| Net income | 451 | 404 | 283 | 245 | 182 | 145 | 100 | 73.2 | 39.1 | 13.4 |
| Net income to common shareholders | 451 | 404 | 283 | 245 | 181 | 145 | 100 | 72.9 | 39.0 | 13.4 |
| Basic EPS | 15.64 | 13.06 | 9.20 | 7.57 | 5.06 | 4.07 | 2.79 | 2.05 | 1.00 | 0.38 |
| Diluted EPS | 15.28 | 12.63 | 8.88 | 7.28 | 4.81 | 3.84 | 2.67 | 1.97 | 0.98 | 0.37 |
| Average shares (basic) | 28.8 | 31.0 | 30.7 | 32.4 | 35.9 | 35.6 | 35.9 | 35.5 | 39.1 | 35.7 |
| Average shares (diluted) | 29.5 | 32.0 | 31.8 | 33.7 | 37.7 | 37.7 | 37.6 | 36.9 | 39.8 | 36.3 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 716 | 707 | 707 | 708 | 660 | 603 | 559 | 537 | 533 | 528 | 511 | 498 |
| Cost of revenue | 205 | 203 | 198 | 182 | 186 | 186 | 178 | 168 | 172 | 172 | 171 | 164 |
| Gross profit | 511 | 505 | 508 | 526 | 474 | 417 | 381 | 369 | 362 | 357 | 340 | 334 |
| Selling, general and administrative | 51.8 | 48.1 | 47.9 | 44.9 | 48.1 | 46.7 | 57.9 | 45.4 | 49.2 | 41.5 | 44.1 | 42.5 |
| Operating income | 166 | 147 | 142 | 153 | 142 | 126 | 114 | 125 | 112 | 105 | 104 | 87.3 |
| EBIT | 166 | 147 | 142 | 153 | 142 | 126 | 114 | 125 | 112 | 105 | 104 | 87.3 |
| EBITDA | 172 | 154 | 148 | 160 | 149 | 133 | 120 | 133 | 120 | 112 | 111 | 94.3 |
| Pre-tax income | 171 | 152 | 148 | 157 | 143 | 125 | 118 | 134 | 119 | 110 | 113 | 90.7 |
| Income tax | 33.4 | 30.3 | 23.7 | 21.7 | 31.7 | 34.3 | 3.6 | 16.9 | 22.4 | 22.1 | 10.2 | 12.4 |
| Net income | 137 | 121 | 124 | 135 | 111 | 90.3 | 115 | 117 | 96.4 | 88.4 | 103 | 78.3 |
| Net income to common shareholders | 137 | 121 | 124 | 135 | 111 | 90.3 | 115 | 117 | 96.4 | 88.4 | 103 | 78.2 |
| Basic EPS | 4.92 | 4.31 | 4.35 | 4.78 | 3.95 | 3.16 | 3.77 | 3.78 | 3.11 | 2.85 | 3.32 | 2.55 |
| Diluted EPS | 4.84 | 4.25 | 4.28 | 4.66 | 3.86 | 3.10 | 3.67 | 3.67 | 3.01 | 2.75 | 3.20 | 2.46 |
| Average shares (basic) | 27.9 | 28.2 | 28.4 | 28.3 | 28.1 | 28.6 | 30.4 | 30.9 | 31.0 | 31.0 | 30.8 | 30.7 |
| Average shares (diluted) | 28.4 | 28.6 | 29.0 | 29.0 | 28.8 | 29.1 | 31.2 | 31.9 | 32.1 | 32.1 | 32.0 | 31.8 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1,975 | 2,101 | 1,657 | 1,352 | 1,660 | 1,391 | 1,143 | 1,005 | 968 | 951 |
| Current assets | 990 | 1,029 | 594 | 334 | 691 | 474 | 317 | 178 | 178 | 130 |
| Cash and equivalents | 497 | 669 | 245 | 28.3 | 461 | 278 | 132 | — | 23.3 | 26.5 |
| Receivables | 427 | 321 | 308 | 265 | 186 | 161 | 156 | — | 133 | 83.1 |
| Net property, plant and equipment | 249 | 252 | 265 | 249 | 223 | 199 | 99.4 | — | 52.3 | 48.7 |
| Goodwill | 662 | 662 | 662 | 662 | 662 | 662 | 662 | — | 661 | 661 |
| Other intangible assets | 33.4 | 34.4 | 35.8 | 38.0 | 41.4 | 46.5 | 54.4 | — | 69.2 | 98.7 |
| Current liabilities | 1,344 | 1,105 | 925 | 803 | 557 | 440 | 343 | 263 | 257 | 193 |
| Accounts payable | 28.1 | 32.5 | 31.9 | 33.1 | 25.7 | 26.6 | 22.4 | — | 16.7 | 16.7 |
| Long-term debt | — | — | — | — | — | — | 0.0 | — | 79.7 | 205 |
| Total debt | 137 | 150 | 164 | 158 | 147 | 131 | 56.2 | — | 106 | 250 |
| Total liabilities | 1,516 | 1,275 | 1,098 | 966 | 707 | 585 | 417 | 406 | 378 | 447 |
| Total equity (incl. minority) | 459 | 826 | 559 | 386 | 953 | 806 | 726 | — | 590 | 504 |
| Retained earnings | -460 | 8.2 | -222 | -360 | 235 | 115 | 68.1 | — | -41.5 | -120 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2,303 | 2,057 | 2,130 | 1,975 | 1,753 | 1,572 | 1,897 | 2,101 | 2,084 | 1,920 | 1,796 | 1,657 |
| Current assets | 1,245 | 1,050 | 1,139 | 990 | 737 | 521 | 821 | 1,029 | 1,033 | 873 | 745 | 594 |
| Cash and equivalents | 705 | 503 | 653 | 497 | 285 | 46.3 | 441 | 669 | 657 | 511 | 407 | 245 |
| Receivables | 448 | 442 | 395 | 427 | 373 | 378 | 298 | 321 | 311 | 301 | 279 | 308 |
| Net property, plant and equipment | 328 | 283 | 263 | 249 | 257 | 265 | 258 | 252 | 255 | 256 | 257 | 265 |
| Goodwill | 662 | 662 | 662 | 662 | 662 | 662 | 662 | 662 | 662 | 662 | 662 | 662 |
| Other intangible assets | 33.0 | 33.1 | 33.3 | 33.4 | 33.7 | 33.9 | 34.1 | 34.4 | 34.7 | 35.1 | 35.4 | 35.8 |
| Current liabilities | 1,496 | 1,435 | 1,345 | 1,344 | 1,284 | 1,220 | 1,122 | 1,105 | 1,041 | 993 | 957 | 925 |
| Accounts payable | 43.7 | 37.5 | 34.4 | 28.1 | 26.5 | 43.3 | 61.3 | 32.5 | 26.2 | 27.4 | 24.4 | 31.9 |
| Total debt | 171 | 144 | 146 | 137 | 144 | 150 | 150 | 150 | 152 | 154 | 158 | — |
| Total liabilities | 1,718 | 1,623 | 1,531 | 1,516 | 1,459 | 1,399 | 1,304 | 1,275 | 1,203 | 1,156 | 1,124 | 1,098 |
| Total equity (incl. minority) | 585 | 434 | 598 | 459 | 294 | 172 | 594 | 826 | 881 | 764 | 672 | 559 |
| Retained earnings | -374 | -511 | -336 | -460 | -596 | -703 | -270 | 8.2 | 65.6 | -30.8 | -119 | -222 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 713 | 609 | 433 | 388 | 263 | 259 | 202 | 157 | 97.4 | 91.7 |
| Depreciation and amortization | 27.2 | 27.8 | 24.1 | 19.0 | 16.0 | 11.7 | 8.4 | 9.2 | 8.6 | 7.4 |
| Capital expenditure | -31.4 | -36.5 | -36.6 | -36.9 | -28.3 | -31.3 | -17.9 | -16.0 | -11.7 | -13.5 |
| Investing cash flow | -31.1 | -28.3 | -34.6 | -38.7 | -31.4 | -31.2 | -19.1 | -17.0 | -12.2 | -13.4 |
| Financing cash flow | -860 | -154 | -183 | -776 | -44.5 | -82.3 | -73.9 | -142 | -97.8 | -58.0 |
| Share repurchases | -917 | -170 | -144 | -848 | -62.1 | -98.3 | 0.0 | 0.0 | -156 | 0.0 |
| Debt issued | 0.0 | 0.0 | 105 | 324 | — | — | — | — | 100 | 165 |
| Debt repaid | 0.0 | 0.0 | -155 | -274 | — | — | -80.4 | -144 | -44.1 | -392 |
| Effect of exchange rates | 5.9 | -2.5 | 1.1 | -6.6 | -4.0 | 0.7 | -0.2 | -1.2 | 1.8 | -0.6 |
| Net change in cash | -172 | 424 | 217 | -433 | 184 | 146 | 109 | -3.2 | -10.9 | 19.7 |
| Free cash flow | 682 | 572 | 397 | 351 | 235 | — | — | — | — | — |
| Levered free cash flow | 472 | 465 | 346 | 296 | 214 | 188 | 152 | 117 | 85.9 | 85.2 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 217 | 162 | 152 | 193 | 246 | 149 | 126 | 191 | 149 | 116 | 153 | 156 |
| Depreciation and amortization | 6.6 | 6.7 | 6.9 | 7.1 | 7.0 | 7.0 | 6.9 | 7.5 | 7.5 | 7.2 | 7.0 | 7.0 |
| Capital expenditure | -20.2 | -23.9 | -6.8 | -4.5 | -10.7 | -6.1 | -10.0 | -7.6 | -10.5 | -12.9 | -5.5 | -10.0 |
| Investing cash flow | -20.1 | -23.9 | -6.7 | -4.5 | -10.7 | -6.0 | -10.0 | -7.6 | -10.5 | -12.8 | 2.5 | -8.0 |
| Financing cash flow | 6.5 | -288 | 12.7 | 22.7 | 3.4 | -541 | -346 | -169 | 6.3 | 0.7 | 7.7 | 1.5 |
| Share repurchases | 0.0 | -295 | 0.0 | 0.0 | -4.6 | -541 | -372 | -170 | — | — | — | — |
| Effect of exchange rates | -0.3 | 0.2 | -2.1 | 0.8 | 0.1 | 3.0 | 2.1 | -2.0 | 1.1 | -0.4 | -1.3 | 0.3 |
| Net change in cash | 203 | -150 | 156 | 212 | 239 | -395 | -228 | 12.5 | 146 | 104 | 162 | 150 |
| Free cash flow | 196 | 138 | 145 | 188 | 235 | 142 | 116 | 183 | 139 | 104 | 147 | 146 |
| Levered free cash flow | 165 | 108 | 100 | 125 | 177 | 88.3 | 81.9 | 164 | 111 | 76.4 | 113 | 137 |
Financial statements of similar companies
Companies in the group: same industry, similar size
